References

  1. Alessandro Pulsoni, SimonaIacobelli, Massimo Bernardi, Marco Borgia, Andrea Camera. M4 acute myeloid leukemia: the role of eosinophilia and cytogenetics in treatment response and survival: the GIMEMA experience. Haematologica. 2008; 93(7): 1025-1032. PubMed | Google Scholar

  2. Appelbaum FR, Kopecky KJ, Tallman MS, et al. The clinical spectrum of adult acute myeloid leukemia associated with core binding factor translocations. Br J Haematol. 2006 Oct;135(2):165-73. PubMed | Google Scholar

  3. Nozomu Kawashima, Akira Shimada, Takeshi Taketani. Childhood acute myeloid leukemia with bone marrow eosinophilia caused by t(16;21)(q24;q22). Int J Hematol. 2012; 95(5):577-80. PubMed | Google Scholar

  4. Van der Reijden BA, de Wit L, van der Poel S. Identification of a novel CBFB–MYH11 transcript: implications for RT–PCR diagnosis. Hematol J. 2001;2(3):206-9. PubMed | Google Scholar

  5. Roumier C, Fenaux P, Lafage M. New mechanisms of AML1 gene alteration in hematological malignancies. Leukemia. 2003 Jan;17(1):9-16. PubMed | Google Scholar

  6. Nikhil A, Sangle, Path FRC, Sherrie Perkins L. Core-Binding Factor Acute Myeloid Leukemia. Arch Pathol Lab Med. 2011 Nov;135(11):1504-9. PubMed | Google Scholar

  7. Nguyen Khac F, Bernard OA. Conséquences moléculaires et fonctionnelles des anomalies chromosomiques des hémopathies malignes humaines. Pathologie Biologie. 2003;51(6):382-389. PubMed | Google Scholar

  8. Reilly JT. Pathogenesis of acute myeloid leukaemia and inv(16)(p13;q22): a paradigm for understanding leukaemogenesis?. Br J Haematol. 2005 Jan;128(1):18-34. PubMed | Google Scholar

  9. Pirc-Danoewinata H, Dauwerse HG, Konig M, Chudoba I, Mitterbauer M, Jager U, et al. CBFB/MYH11 fusion in a patient with AML-M4Eo and cytogenetically normal chromosomes 16. Genes Chromosomes Cancer. 2000 Oct;29(2):186-91. PubMed | Google Scholar

  10. DastugueN. The interest of standard and molecular cytogenetics for diagnosis of acute leukemia. Pathol Biol (Paris). 2003 Aug;51(6):337-45. PubMed | Google Scholar

  11. Jana Ellegast M, Bernhard Gerber und Markus Manz G. Diagnostic et traitement de la leucémie myéloïde aiguë. Forum Med Suisse. 2013;13(6):112–119. PubMed | Google Scholar

  12. NCCN Clinical Practice Guidelines in Oncology: Acute Myelogenous Leukemia. Available at http://www.nccn.org/. PubMed | Google Scholar

  13. Brauna C, Duffaua P, Mahonb F-X, Rosierc E, Leguayd T, Étiennee G, Michaudb M. Acute pancreatitis due to hypercalcemia revealing adult T-cell leukaemia. La Revue de Médecine Interne. February 2007;28(2):116–119. PubMed | Google Scholar

  14. Ploussard S, Auvrignon A, Leblanc T, Nelken B. Survenued’unepancréatite au cours du traitement des Leucémies Aiguës Myéloblastiques de l’enfant et de l’adolescent dans le protocole multicentrique ELAM02 : rôle de la cytarabine. Hématologie. Mars 2012; 18:S1. PubMed | Google Scholar

  15. Susan L, Kearney MD, Suzanne Dahlberg E. Clinical course and outcome in children with acute lymphoblastic leukemia and asparaginase-associated pancreatitis. Pediatric Blood & Cancer. August 2009;53(2):162–167. PubMed | Google Scholar

  16. Gülpamukcua, Ayferkelesa, Ahmet Demircana, Fikret Bildika, Gülbinaygencelb, Sertaçgülera. Paroxetine-Induced Acute Pancreatitis: Case Report/ParoksetineBagliAkutPankreatit. TurkiyeKlinikleri J Gastroenterohepatol. 2009;16(2):84-7. PubMed | Google Scholar

  17. Mallory A, Kern F. Drug-induced pancreatitis: a critical review. Gastroenterology. 1980 Apr;78(4):813-20. PubMed | Google Scholar

  18. Biour M, et al. Drug-induced pancreatitis: first updated edition of the bibliographic database of acute pancreatitis and related drugs. Gastroenterol Clin Biol. 2001;25(Suppl 1):S22-7. PubMed | Google Scholar